Mauna Kea Technologies (Mauna Kea Technologies) 3-Year Revenue Growth Rate : -2.60% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies 3-Year Revenue Growth Rate?

Mauna Kea Technologies's Revenue per Share for the six months ended in Dec. 2023 was $0.06.

During the past 12 months, Mauna Kea Technologies's average Revenue per Share Growth Rate was 17.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was -9.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Mauna Kea Technologies was 18.40% per year. The lowest was -26.90% per year. And the median was -13.00% per year.

Competitive Comparison of Mauna Kea Technologies's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Mauna Kea Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mauna Kea Technologies's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's 3-Year Revenue Growth Rate falls into.

Mauna Kea Technologies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Mauna Kea Technologies (OTCPK:MKEAF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Mauna Kea Technologies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ALMKT:France 1MK:Germany

Address

9, rue d'Enghien, Paris, FRA, 75010

Website

https://www.maunakeatech.com

Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines

From GuruFocus

Q1 2022 Mauna Kea Technologies SAS Earnings Call Transcript

By GuruFocus Research • 03-01-2024

Q4 2020 Mauna Kea Technologies SAS Earnings and Q1 2021 Sales Release Transcript

By GuruFocus Research • 03-01-2024